Evalve, Inc. was a medical-device company that pioneered percutaneous (catheter-based) mitral valve repair with its MitraClip system for treating mitral regurgitation. It was acquired by Abbott Laboratories in 2009 (~$410M) and folded into Abbott Structural Heart / Abbott Vascular; MitraClip is now an Abbott product. - View it on GitHub